Navigation Links
Fulgent Therapeutics Announces Their Comprehensive Hereditary Cancer Test Including BRCA1 and BRCA2 Analysis
Date:6/14/2013

Temple City, CA (PRWEB) June 14, 2013

Fulgent Therapeutics LLC, a CLIA Certified Laboratory, announces the inclusion of BRCA1 and BRCA2 analysis to its Hereditary Cancer Panel. Fulgent Therapeutics is excited to add these key targets, making it the most comprehensive test for cancer risk assessment available.

Fulgent Therapeutics Hereditary Cancer Panel detects mutations in 49 known cancer predisposition genes, now including BRCA1 and BRCA2. “We use well defined processes, robust bioinformatics, and Next Generation Sequencing to provide our clients with a comprehensive look at a true myriad of genes,” according to Dr. Harry Gao, Lab Director for Fulgent Therapeutics.

Personalized medicine demands that we examine diseases in new ways and deploy innovative tools to view all angles of the patient’s health and potential diseases. Fulgent Therapeutics Hereditary Cancer Panel provides patients and physicians with the information to assess their risks and guide their care. “Making molecular diagnostics more comprehensive and at the same time more affordable is our goal,” says Dr. Gao.

Fulgent Therapeutics president, Ming Hsieh stated, “We agree with the Supreme Court’s decision and we look forward to providing physicians with better tools and more options to help their patients."

Fulgent Therapeutics is currently working on panels for more than just cancer. The Next Generation panels for many inherited disease including cardiology, pediatrics, and neurology will provide physicians with more information than previously available.

The release date for the Hereditary Cancer Panel, including BRCA1 and BRCA2, will be available July 8, 2013. Fulgent Therapeutics anticipates that it will provide another first to the industry by getting the 49-gene panel’s price under $3,000.

Additional information: info(at)fulgent-therapeutics(dot)com or 626-350-0537 x106.

About Fulgent Th
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Mainz University obtains new CRC Nanodimensional polymer therapeutics for tumor therapy
2. MDA Awards Valerion Therapeutics $1.2 Million to Continue Myotubular Myopathy Research
3. Corena Therapeutics Launched Coresatin, a Nonsteroidal Cream Used to Treat Critical Skin Conditions and Infections
4. Global Peptide Therapeutics Market - New Market Research Report Published by Transparency Market Research
5. Liver Diseases Therapeutics Market - New Industry Research Report Published by Transparency Market Research
6. Ontario Genomics Institute invests in stem cell technology at Tissue Regenerative Therapeutics
7. Scientist receives $2.8 Million to study cell signaling mechanism and develop potential therapeutics
8. Cancer vaccine Special Focus series published in Human Vaccines & Immunotherapeutics
9. Research shows potential of microneedles to target therapeutics to the back of the eye
10. Media alert: 24th EORTC - NCI - AACR Symposium Molecular Targets and Cancer Therapeutics
11. FORMA Therapeutics teams with TGen Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... Could one day lead to treatments for baldness, researchers ... have taken a step forward in understanding the mechanisms ... some women, for all of history: hair loss. , ... hair follicles to start the hair-growing cycle. , "These ...
... Mylan Inc. (NYSE: MYL ),today announced that ... company has declared its quarterly dividend of $16.25 per,share ... a liquidation,preference of $1,000.00 per share) payable on August ... of August 1, 2008., Mylan Inc., with operations ...
... ATRC ), a medical device company and a leader in ... following,investor conferences during August:, -- The BMO Focus on ... the Millennium Broadway Hotel in New York. David J. Drachman, President ... present at 9:00 a.m. Eastern time., ...
... State of Michigan to spray the state,s apple orchards ... antibiotic to treat blood infections in newborns and other ... of America (IDSA). , The Environmental Protection Agency ... permission to use gentamicin to fight a tree disease ...
... Pat Phalin learned she had hearing loss at 30, ... school. The pupils heard sounds she could not hear. ... in his wife,s family history. Her mother, grandfather and great-grandfather ... children had hearing problems before he reached school age. ...
... 31, 2008 The AMERIGROUP Foundation, the,philanthropic arm ... for Children,s (UMHC) Breathmobile at a ceremony today ... Maryland Chief Operating Officer Vince Ancona presented a,contribution ... the AMERIGROUP,Foundation. The UMHC Breathmobile is a custom-built ...
Cached Medicine News:Health News:Mouse Study Finds Molecule That Tells Hair to Grow 2Health News:AtriCure to Present at the BMO Focus on Healthcare and Canaccord Adams Global Growth Conferences in August 2Health News:Physicians ask EPA, 'Antibiotics to cure sick apples, or sick children?' 2Health News:Inherited form of hearing loss stems from gene mutation 2Health News:Inherited form of hearing loss stems from gene mutation 3Health News:The AMERIGROUP Foundation Honors the University of Maryland Hospital for Children's Breathmobile 2
(Date:1/15/2014)... 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ... "Dental Consumables Market - Global Industry Analysis, Size, ... report to their offering. ... Dental consumables are products which are used on ... tooth restoration and in treatment of associated gingival ...
(Date:1/15/2014)... LAWRENCEVILLE, N.J. , Jan. 15, 2014  Celsion ... today announced that it has received commitments from ... $15 million of the Company,s common stock in ... dedicated health care fund. The Company ... pursuant to which the Company agreed to sell ...
(Date:1/15/2014)... -- BreedIT Corp (OTC: BRDT), through its ... highly sophisticated agro-breeding solutions for plant breeders and researchers, ... board of directors appointed chemistry and pharmaceutical industry expert ... of the board. From 1975 to 2012, ... Ltd (NYSE: TEVA ) and its subsidiaries ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... 2011 Hospira, Inc. (NYSE: HSP ), a ... that it will host a conference call to discuss its ... a.m. Central time. The company will release its ... open and the conference call. A live webcast ...
... DEL REY, Calif., April 4, 2011 Dr. Richard Merkin, ... official launch of the $3 million dollar Heritage Health Prize, ... celebrating the launch of the contest at the Data 2.0 ... interest in data mining and analytics to enter the $3 ...
Cached Medicine Technology:Heritage Provider Network Announces the Official Launch of the $3 million Dollar Heritage Health Prize 2Heritage Provider Network Announces the Official Launch of the $3 million Dollar Heritage Health Prize 3
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
... The TC-PLUS Solution tricompartmental total knee prosthesis ... knee arthroplasty. State-of-the-art design and manufacturing technologies ... optimum biomechanical function as well as a ... tibial insert to keep wear to a ...
... Knee System is a long term, quality ... Available in both posterior stabilized and anatomically ... System provides the flexibility needed to address ... ease of identification keeps the user in ...
... a long term, quality solution based on ... posterior stabilized and anatomically correct cruciate retaining ... flexibility needed to address patients' needs. In ... keeps the user in mind and promotes ...
Medicine Products: